Moderna Investors Should Brace for More Whiplash
Even after its latest sharp fall, the drugmaker’s stock price assumes wild successes.
We haven't written up this one. WSJ Markets has the full story — the link below goes straight to it.
More in Finance & Markets
Access Holdings has built scale; now comes the test of creating value
After two decades of acquisition-led growth, one of Africa's most widely spread banking groups has made returns, not reach, its measure of success.
Should You Buy Netflix Stock After Its 51% Plunge?
Key PointsNetflix stock has plummeted by 51% from last year's record high, as investors worry the company's best days might be behind it.
Fodder scam case: CBI nabs Satyendra Kumar, accused on the run for 25 years from Lucknow station; all you need to know
The CBI arrested fodder scam accused Satyendra Kumar at Lucknow railway station after 25 years on the run. Traced to Nepal before returning to India, he is being brought to Ranchi on transit remand to…
Looking Beyond the S&P 500? These 2 International ETFs Offer Very Different Opportunities
One fund targets developed markets with ultra-low fees and higher yields, while the other emphasizes emerging-market growth with heavy tech exposure.
Coinbase vs. Paypal: Two Fintech Giants, Two Very Different Price Tags. Which Stock Wins?
Key PointsCoinbase Global serves as a critical gateway for institutional and retail cryptocurrency infrastructure.
